United Health Products Inc.'s Epic Wound Care Inc. Announces Agreement with Ryan Network for Beta Test of United's HemoStyp™ Wound Care Product
United Health Products, Inc.'s www.unitedhealthproductsinc.com
(OTCQB: UEEC.PK) wholly owned subsidiary, Epic Wound Care, Inc., which
develops and markets products and technologies in the healthcare sector,
is pleased to announce that it has entered into a beta test agreement
with the distinguished Ryan Network for UEEC's hemostatic gauze. The
gauze is registered and branded in the USA under the trademark
HemoStyp™. Under the beta test protocol, the HemoStyp™ gauze will be
indicated for patients post venipuncture to assess expedited
coagulation, ease of use, patient satisfaction, and decrease prolonged
coagulation due to patients co-morbidities and anticoagulation therapy.
The Ryan Network was founded upon former Congressman William F. Ryan's
belief that "health care is a right, not a privilege." Ryan Network is a
family of not-for-profit, federally qualified health centers with
multiple locations in New York City. In July 2011, medical residents and
attending preceptor physicians from St. Luke's-Roosevelt Hospital Center
(SLRHC) began providing front-line primary medical care in Ryan's Adult
Medicine Department as part of their training in the Medical Residency
Program/SLRHC. The Network's other sites, Ryan-NENA (2011 - Beth Israel
Hospital), Ryan Chelsea-Clinton (2007 - Roosevelt Hospital) and
Ryan/Adair (2009 - SLRHC), also have medical residents in place (in some
cases, for several years), to the mutual benefit of Ryan's patients and
the Medical Residency Program. The Network's service sites also include
the new Ryan Women & Children's Center, clinics at four family living
transitional shelters, one rehabilitation center and six school-based
health centers. The service sites are fully coordinated with all
services at the main center sites.
HemoStyp™ is a gauze specifically formulated to produce hemostasis
almost instantly when positioned on a cut or wound. It contains no
potentially harmful chemicals such as thrombin, collagen or animal
byproducts, is hypoallergenic and works more quickly than other
hemostatic agents. Once it has completed its task, it is readily
dissolved by saline solution or water for easy removal that neither
disturbs the clotted surface nor encourages re-bleeding.
Dr. Phillip Forman, CEO of United Health Products Inc., stated, "The
Ryan Network delivers world-class medical care to diverse and
underserved communities, and their commitment to the beta testing is one
more way they can deliver on that promise to those communities.” Dr.
Forman hoped to have the results of the specific study parameters and
data collection available within 60 days.
More information about the Ryan Network can be found here: http://www.ryancenter.org/home.htm
About United Health Products, Inc.
United Health Products, Inc. (UEEC) develops, manufactures, and markets
products and technologies in the healthcare sector. UEEC's operating
subsidiary Epic Wound Care, Inc. produces hemostatic gauze, derived from
regenerated oxidized cellulose, which is all natural, and designed to
absorb exudate/drainage from superficial wounds and helps control
bleeding. UEEC is focused on identifying emerging healthcare products
and technologies for strategic partnership or acquisition. For more on
United Health Products, Inc. visit: www.unitedhealthproductsinc.com
Safe Harbor Statement
Safe Harbor Statement under the Private Securities Litigation Reform Act
of 1995: This news release may contain forward-looking information
within the meaning of Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities Exchange Act of 1934, as
amended, including statements that include the words "believes,"
"expects," "anticipates" or similar expressions. Such forward-looking
statements involve known and unknown risks, uncertainties and other
factors that may cause the actual results, performance or achievements
of the Company to differ materially from those expressed or implied by
such forward-looking statements.
